These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7178213)

  • 61. Prolactin release in response to infusion of isotonic or hypertonic saline.
    Bliss DJ; Lote CJ
    J Endocrinol; 1982 Feb; 92(2):273-8. PubMed ID: 7061951
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Amperozide--effect on prolactin release in the rat.
    Albinsson A; Eriksson E; Andersson G
    Pharmacol Toxicol; 1990; 66 Suppl 1():49-51. PubMed ID: 2304896
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The effect of ethanol on prolactin secretion in vitro.
    Seilicovich A; Duvilanski BH; Debeljuk L; Díaz MC; Muñoz Maines V; Rettori V
    Life Sci; 1984 Nov; 35(19):1931-5. PubMed ID: 6493000
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Partial dopamine D2 receptor agonists antagonize prolactin-regulating D2 receptors in a transfected clonal cell line (GH4ZR7).
    Nilsson C; Eriksson E
    Eur J Pharmacol; 1992 Aug; 218(2-3):205-11. PubMed ID: 1358634
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Activity of tuberoinfundibular dopaminergic neurons and concentrations of serum prolactin in the rat following lithium administration.
    Gudelsky GA; Koenig JI; Koyama T; Meltzer HY
    Psychopharmacology (Berl); 1988; 94(1):92-6. PubMed ID: 3126532
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Interaction between estradiol and prolactin on vasoactive intestinal peptide concentrations in the hypothalamus and in the anterior pituitary of the female rat.
    Maletti M; Rostene WH; Carr L; Scherrer H; Rotten D; Kordon C; Rosselin G
    Neurosci Lett; 1982 Oct; 32(3):307-13. PubMed ID: 6891038
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dopamine levels in the anterior pituitary gland monitored by in vivo electrochemistry.
    Mulchahey JJ; Neill JD
    Brain Res; 1986 Oct; 386(1-2):332-40. PubMed ID: 3779414
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Further evidence that peptide histidine isoleucine (PHI) may function as a prolactin releasing factor in rats.
    Ohta H; Kato Y; Tojo K; Shimatsu A; Inoue T; Kabayama Y; Imura H
    Peptides; 1985; 6(4):709-12. PubMed ID: 3934651
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Further evidence on the direct action of L-Dopa on prolactin release.
    Donoso AO; Banzán AM; Barcaglioni JC
    Neuroendocrinology; 1974; 15(3-4):236-9. PubMed ID: 4420786
    [No Abstract]   [Full Text] [Related]  

  • 70. Basal and dopamine-inhibited prolactin secretion by rat anterior pituitary cells: effects of culture conditions.
    Oosterom R; Verleun T; Lamberts SW
    Mol Cell Endocrinol; 1983 Feb; 29(2):197-212. PubMed ID: 6832471
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The participation of hypothalamic dopamine in morphine-induced prolactin release in man.
    Delitala G; Grossman A; Besser GM
    Clin Endocrinol (Oxf); 1983 Oct; 19(4):437-44. PubMed ID: 6627697
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of mesulergine on prolactin secretion and dopamine D2 receptors-adaptive changes in diethylstilbestrol-induced hyperplasia of the rat anterior pituitary.
    Pisarek H; Stepien H; Pawlikowski M
    Endocr Regul; 1992 Mar; 26(1):17-22. PubMed ID: 1421203
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Vasoactive intestinal peptide and the stimulation of lactotroph growth by oestradiol in rats.
    Prysor-Jones RA; Silverlight JJ; Kennedy SJ; Jenkins JS
    J Endocrinol; 1988 Feb; 116(2):259-65. PubMed ID: 3351421
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Lipopolysaccharide- and tumor necrosis factor-alpha-induced changes in prolactin secretion and dopaminergic activity in the hypothalamic-pituitary axis.
    De Laurentiis A; Pisera D; Caruso C; Candolfi M; Mohn C; Rettori V; Seilicovich A
    Neuroimmunomodulation; 2002; 10(1):30-9. PubMed ID: 12207161
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Involvement of brain dopamine in prolactin secretion induced by a synthetic Met5-enkephalin analogue in rats.
    Matsushita N; Kato Y; Katakami H; Shimatsu A; Imura H
    Endocrinol Jpn; 1982 Jun; 29(3):277-85. PubMed ID: 7173110
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Estradiol-induced prolactinomas: differential effects on dopamine in posterior pituitary and median eminence.
    Burgett RA; Garris PA; Ben-Jonathan N
    Brain Res; 1990 Oct; 531(1-2):143-7. PubMed ID: 2289118
    [TBL] [Abstract][Full Text] [Related]  

  • 77. In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen.
    Hurd YL; Ungerstedt U
    Eur J Pharmacol; 1989 Jul; 166(2):251-60. PubMed ID: 2477259
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cortisol secretion following nomifensine administration in normal subjects.
    Alagna S; Masala A
    Biomedicine; 1979 Nov; 31(7):189-91. PubMed ID: 526541
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The effect of hypophysectomy and subsequent prolactin replacement or of elevated prolactin alone on median eminence noradrenaline and dopamine in the rat.
    Morgan WW; Herbert DC; Pfeil KA
    Endocrinology; 1982 May; 110(5):1584-91. PubMed ID: 7075532
    [No Abstract]   [Full Text] [Related]  

  • 80. Enhancement of stereotypy induced by nomifensine in rats during continuous chronic haloperidol treatment.
    Rupniak NM; Jenner P; Marsden CD
    Neurosci Lett; 1984 Sep; 50(1-3):63-5. PubMed ID: 6541767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.